- Home
- ADVB vs BFRI Comparison
ADVB vs BFRI Comparison
Compare ADVB & BFRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADVB
- BFRI
- Stock Information
- Founded
- ADVB 2014
- BFRI 1997
- Country
- ADVB United States
- BFRI United States
- Employees
- ADVB N/A
- BFRI N/A
- Industry
- ADVB Medical Specialities
- BFRI Biotechnology: Pharmaceutical Preparations
- Sector
- ADVB Health Care
- BFRI Health Care
- Exchange
- ADVB Nasdaq
- BFRI Nasdaq
- Market Cap
- ADVB 12.2M
- BFRI 10.6M
- IPO Year
- ADVB 2025
- BFRI 2021
- Fundamental
- Price
- ADVB $0.46
- BFRI $1.06
- Analyst Decision
- ADVB
- BFRI Strong Buy
- Analyst Count
- ADVB 0
- BFRI 1
- Target Price
- ADVB N/A
- BFRI $2.75
- AVG Volume (30 Days)
- ADVB 947.6K
- BFRI 93.2K
- Earning Date
- ADVB 10-27-2025
- BFRI 11-13-2025
- Dividend Yield
- ADVB N/A
- BFRI N/A
- EPS Growth
- ADVB N/A
- BFRI N/A
- EPS
- ADVB N/A
- BFRI N/A
- Revenue
- ADVB N/A
- BFRI $39,188,000.00
- Revenue This Year
- ADVB N/A
- BFRI $9.70
- Revenue Next Year
- ADVB N/A
- BFRI $12.58
- P/E Ratio
- ADVB N/A
- BFRI N/A
- Revenue Growth
- ADVB N/A
- BFRI 11.20
- 52 Week Low
- ADVB $0.34
- BFRI $0.54
- 52 Week High
- ADVB $4.10
- BFRI $2.22
- Technical
- Relative Strength Index (RSI)
- ADVB 49.73
- BFRI 56.80
- Support Level
- ADVB $0.43
- BFRI $0.95
- Resistance Level
- ADVB $0.62
- BFRI $1.15
- Average True Range (ATR)
- ADVB 0.06
- BFRI 0.06
- MACD
- ADVB 0.00
- BFRI 0.00
- Stochastic Oscillator
- ADVB 28.36
- BFRI 64.00
About ADVB Advanced Biomed Inc. Common Stock
Advanced Biomed Inc operates through its subsidiaries that are responsible for the main operation and the design and development of the company's primary technologies and products. It has been focusing on the integration of multiple interdisciplinary technologies and established its microfluidic technology platform. Utilizing the physical and molecular biological characteristics of tumor cells, the company has developed various advanced and original research through the joint application of semiconductor technology and biotechnology. devices, A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.
About BFRI Biofrontera Inc.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions.